Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-21-005129
Filing Date
2021-08-03
Accepted
2021-08-03 16:19:13
Documents
2
Period of Report
2021-08-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4133
2 TIM DEMUTH POA tdemuthpoa.txt EX-24 3314
  Complete submission text file 0001562180-21-005129.txt   8934
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109
Business Address
Demuth Tim (Reporting) CIK: 0001875267 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 211140047